Cargando…

Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by (18)F-FDG-PET is associated with the KRAS mutation status and prognosis

BACKGROUND: Surgical resection remains the mainstay of curative treatment for intrahepatic cholangiocarcinoma (ICC). Prognosis after surgery is unsatisfactory despite improvements in treatment and post-operative clinical management. Despite developments in the molecular profiling of ICC, the preoper...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikeno, Yoshinobu, Seo, Satoru, Iwaisako, Keiko, Yoh, Tomoaki, Nakamoto, Yuji, Fuji, Hiroaki, Taura, Kojiro, Okajima, Hideaki, Kaido, Toshimi, Sakaguchi, Shimon, Uemoto, Shinji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896043/ https://www.ncbi.nlm.nih.gov/pubmed/29642912 http://dx.doi.org/10.1186/s12967-018-1475-x

Ejemplares similares

Mass-forming intrahepatic cholangiocarcinoma with portal vein tumor thrombus and bile duct tumor thrombus: A case report
por: Iwaki, Kentaro, et al.
Publicado: (2017)

Controversies over the Epithelial-to-Mesenchymal Transition in Liver Fibrosis
por: Taura, Kojiro, et al.
Publicado: (2016)

Living donor liver transplantation for adult Budd Chiari syndrome – Resection without replacement of retrohepatic IVC: A case report
por: Sabra, Tarek Abdelazeem, et al.
Publicado: (2017)

Sclerosing encapsulating peritonitis after living-donor liver transplantation: A case series, Kyoto experience
por: Aliyev, Vusal, et al.
Publicado: (2018)

Structure and surgical dissection layers of the bare area of the liver
por: Ishii, Takamichi, et al.
Publicado: (2020)

Gene expression profiles of liver cancer cell lines reveal two hepatocyte-like and fibroblast-like clusters
por: Fukuyama, Keita, et al.
Publicado: (2021)

Long-term Prognosis and Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A Single-Center Experience
por: Ueda, Yoshihide, et al.
Publicado: (2017)

Spontaneous clearance of hepatitis C virus after liver transplantation: a report of four cases
por: Tamaki, Ichiro, et al.
Publicado: (2015)

Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma
por: Murakami, Yoshiki, et al.
Publicado: (2015)

A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion
por: Ikenoue, Tsuneo, et al.
Publicado: (2016)

Nardilysin promotes hepatocellular carcinoma through activation of signal transducer and activator of transcription 3
por: Kasai, Yosuke, et al.
Publicado: (2017)

The Role of Mesothelin in Activation of Portal Fibroblasts in Cholestatic Liver Injury
por: Nishio, Takahiro, et al.
Publicado: (2022)

Strategies to Detect Hepatic Myofibroblasts in Liver Cirrhosis of Different Etiologies
por: Iwaisako, Keiko, et al.
Publicado: (2014)

Corrigendum: A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion
por: Ikenoue, Tsuneo, et al.
Publicado: (2017)

Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma
por: Ishii, Takamichi, et al.
Publicado: (2020)

Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation
por: Cavalloni, Giuliana, et al.
Publicado: (2016)

Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
por: Peng, Jianbo, et al.
Publicado: (2023)

Genetic features associated with (18)F-FDG uptake in intrahepatic cholangiocarcinoma
por: Ahn, Keun Soo, et al.
Publicado: (2019)

Foxp3+ Regulatory T Cells Inhibit CCl(4)-Induced Liver Inflammation and Fibrosis by Regulating Tissue Cellular Immunity
por: Ikeno, Yoshinobu, et al.
Publicado: (2020)

Proposal for new selection criteria considering pre‐transplant muscularity and visceral adiposity in living donor liver transplantation
por: Hamaguchi, Yuhei, et al.
Publicado: (2018)

A Minimal Physiologically‐Based Pharmacokinetic Model for Tacrolimus in Living‐Donor Liver Transplantation: Perspectives Related to Liver Regeneration and the cytochrome P450 3A5 (CYP3A5) Genotype
por: Itohara, Kotaro, et al.
Publicado: (2019)

Association of KRAS Variant Subtypes With Survival and Recurrence in Patients With Surgically Treated Intrahepatic Cholangiocarcinoma
por: Zhou, Shao-Lai, et al.
Publicado: (2021)

TP53 /KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic Cholangiocarcinoma
por: Guo, Chunguang, et al.
Publicado: (2022)

Cholangiocarcinoma after flow diversion surgery for congenital biliary dilatation: A case report and review of literature
por: Ataka, Ryo, et al.
Publicado: (2019)

Oncogenic KRAS Requires Complete Loss of BAP1 Function for Development of Murine Intrahepatic Cholangiocarcinoma
por: Marcus, Rebecca, et al.
Publicado: (2021)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

Living donor liver transplantation for combined hepatocellular-cholangiocarcinoma: A case series of four patients
por: Ito, Takashi, et al.
Publicado: (2020)

Suppression of intrahepatic cholangiocarcinoma cell growth by SKI via upregulation of the CDK inhibitor p21
por: Kawamura, Etsushi, et al.
Publicado: (2022)

Utility of KRAS mutational analysis in the preoperative diagnosis of synchronous pancreatic cancer and intrahepatic cholangiocarcinoma: A case report
por: Eso, Yuji, et al.
Publicado: (2017)

Detection of distant metastasis to skeletal muscle by (18)F-FDG-PET in a case of intrahepatic cholangiocarcinoma
por: Park, Se Kyung, et al.
Publicado: (2010)

Two Varieties of Intrahepatic Cholangiocarcinoma
por: Nagorney, David M.
Publicado: (1994)

Intrahepatic Cholangiocarcinoma with Sarcomatous Changes
por: Inoue, Yoshiyuki, et al.
Publicado: (2012)

Serum Markers of Intrahepatic Cholangiocarcinoma
por: Malaguarnera, Giulia, et al.
Publicado: (2013)

Intrahepatic cholangiocarcinoma: current perspectives
por: Buettner, Stefan, et al.
Publicado: (2017)

Intratumoral heterogeneity of intrahepatic cholangiocarcinoma
por: Walter, Dirk, et al.
Publicado: (2017)

Molecular heterogeneity in intrahepatic cholangiocarcinoma
por: Ahn, Keun Soo, et al.
Publicado: (2020)

Recurrent Intrahepatic Cholangiocarcinoma – Review
por: Bekki, Yuki, et al.
Publicado: (2021)

Stereotactic radiotherapy for intrahepatic cholangiocarcinoma
por: Borakati, Aditya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_26ecfbpd09b8ap1i8nsro1t2sq